Treace Medical Concepts, Inc. TMCI Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Treace Medical Concepts, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s stock-based comp?
- Treace Medical Concepts, Inc. (TMCI) reported stock-based comp of $8.03M in Q1 2026.
- How has Treace Medical Concepts, Inc.'s stock-based comp changed year-over-year?
- Treace Medical Concepts, Inc.'s stock-based comp decreased by 7.6% year-over-year, from $8.69M to $8.03M.
- What is the long-term trend for Treace Medical Concepts, Inc.'s stock-based comp?
- Over 4 years (2021 to 2025), Treace Medical Concepts, Inc.'s stock-based comp has grown at a 77.5% compound annual growth rate (CAGR), from $3.41M to $33.82M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.